Skip to main content
Clinical Trials/JPRN-UMIN000038098
JPRN-UMIN000038098
Completed
未知

Optimal intrathecal hyperbaric bupivacaine dose with opioids for cesarean delivery - Optimal intrathecal hyperbaric bupivacaine dose with opioids for cesarean delivery

Department of Anesthesiology, Tohoku Kosai Hospital0 sites34 target enrollmentSeptember 25, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
cesarean delivery
Sponsor
Department of Anesthesiology, Tohoku Kosai Hospital
Enrollment
34
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 25, 2019
End Date
October 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Department of Anesthesiology, Tohoku Kosai Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • active labor, ruptured membranes, \>\=3 previous cesarean deliveries, gestational diabetes, pregnancy\-induced hypertension, intrauterine growth retardation, placenta previa or a body mass index \>\=35

Outcomes

Primary Outcomes

Not specified

Similar Trials